Serum amyloid a protein and c-reactive protein in normal pregnancy and preeclampsia

Gynecologic and Obstetric Investigation

Volumn 67, Issue 4, 2009, Pages 275-280

  Kristensen, K ^a   Wide Swensson, D ^a   Lindstrom V ^a   Schmidt, C ^b   Grubb, A ^a   Strevens, H ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

Acute phase; Ceruloplasmin; Haptoglobin; Orosomucoid; Plasma; Protein

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; CERULOPLASMIN; HAPTOGLOBIN; OROSOMUCOID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; C-REACTIVE PROTEIN; CERULOPLASMIN; FEMALE; HAPTOGLOBINS; HUMANS; IMMUNOASSAY; OROSOMUCOID; PRE-ECLAMPSIA; PREGNANCY; SERUM AMYLOID A PROTEIN;

EID: 65449145191     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214081     Document Type: Article

References (25)

1. Roberts JM: Endothelial dysfunction in pre-eclampsia. Semin Reprod Endocrinol 1998; 16: 5-15.
2. Redman CW, Sacks GP, Sargent IL: Pre-eclampsia: an excessive maternal inflammatory response to pregna ncy. Am J Obste t Gynecol 1999; 180:499-506.
3. Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al: Serum cystatin C reflects glomerular endo-theliosis in normal, hypertensive and preeclamptic pregnancies. BJOG 2003; 110: 825- 830.
4. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M: Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993; 39:293-297.
5. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
6. Thorn CF, Lu ZY, Whitehead AS: Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, in-terleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 2004; 59: 152-158.
7. Blake GJ, Ridker PM: Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
8. Sacks GP, Studena K, Sargent K, Redman CW: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80- 86.
9. Romem Y, Artal R: C-reactive protein in pregnancy and in the postpartum period. Am J Obstet Gynecol 1985; 151: 380-383.
10. Sacks GP, Seyani L, Lavery S, Trew G: Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004; 19:1025- 1030.
11. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R: Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001; 98: 757-762.
12. Teran E, Escudero C, Moya W, Flores M, Val-lance P, Lopez-Jaramillo P: Elevated C-reactive protein and pro-inflammatory cyto-kines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 2001; 75:243-249.
13. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, et al: Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123: 46-51.
14. Braekke K, Holthe MR, Harsem NK, Fagerhol MK, Staff AC: Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol 2005; 193: 227-233.
15. Engin-Ustun Y, Ustun Y, Karabulut AB, Oz-kaplan E, Meydanli MM, Kafkasli A: Serum amyloid A levels are increased in pre-ec-lampsia. Gynecol Obstet Invest 2007; 64: 117- 120.
16. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
17. ACOG technical bulletin: Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996; 53:175-183.
18. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR: Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2006; 27: 27.
19. Trepels T, Zeiher AM, Fichtlscherer S: The endothelium and inflammation. Endothelium 2006; 13:423-429.
20. Spinnato JA 2nd: New therapies in the prevention of preeclampsia. Curr Opin Obstet Gynecol 2006; 18:601-604.
21. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S, et al: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70: 83-91.
22. Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH: Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG 2002; 109: 297- 301.
23. Bottorff MB, Pieper JA, Boucher BA, Hoon TJ, Ramanathan J, Sibai BM: Lidocaine protein binding in preeclampsia. Eur J Clin Pharmacol 1987; 31: 719-722.
24. Skjoldebrand Sparre L, Carlstrom A, von Schoultz B, Carlstrom K: Serum levels of an-drogens and estrogens and 'steroid-sensitive' liver proteins in early human pregnancy: influence on the gender of the offspring. Gynecol Obstet Invest 1995; 40: 145-150.
25. Vitoratos N, Salamalekis E, Dalamaga N, Kassanos D, Creatsas G: Defective antioxi-dant mechanisms via changes in serum ce-ruloplasmin and total iron binding capacity of serum in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1999; 84: 63- 67.